Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Biomatech is a leading European contract research organization (CRO) specializing in the evaluation of medical devices and biomaterials. Based in France, the company provides a comprehensive suite of services including biocompatibility testing, preclinical surgical studies, and clinical trial management. In 2009, Biomatech was acquired by NAMSA (North American Science Associates), a global medical device CRO, to expand its European footprint and service capabilities. Today, the entity operates as a key part of NAMSA's global laboratory and clinical network, supporting manufacturers in navigating complex regulatory pathways and ensuring product safety and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biomatech.